Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
Clinical trial NCT02296203 · UNKNOWN
Trial details
- NCT number
- NCT02296203
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-06-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.